Oncology Board Review: Blueprint Study Guide and Q&A | Agenda Bookshop Skip to content
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
LAST CHANCE! Order items marked '10-20 working days' TODAY to get them in time for Christmas!
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Erin Cobain
B01=Francis P. Worden
B01=Rami N. Khoriaty
Category1=Non-Fiction
Category=MJ
Category=MJCL
Category=MJF
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€50 to €100
PS=Active
softlaunch

Oncology Board Review: Blueprint Study Guide and Q&A

English

Includes 6 months' free ExamPrepConnect Digital Access with print purchase!

Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive print + digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions, detailed rationales, and a convenient print + digital package, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time!

Key Features:

  • Aligns with the latest ABIM Medical Oncology Certification Exam blueprint
  • Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors
  • Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam
  • Revised to include new treatment recommendations and FDA approvals
  • Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout
  • Content available digitally via ExamPrepConnect for study on the go

ExamPrepConnect Features:

  • All the high-quality content from the book
  • Personalized study plan based on initial certification or MOC exam date
  • Ability to study by topic area to identify strengths and weaknesses
  • Timed practice test that simulates the test-taking environment
  • Discussion board to connect with Medical Oncology exam-prep community

See access details inside the book.

See more
Current price €79.79
Original price €83.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Erin CobainB01=Francis P. WordenB01=Rami N. KhoriatyCategory1=Non-FictionCategory=MJCategory=MJCLCategory=MJFCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€50 to €100PS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 751g
  • Dimensions: 152 x 229mm
  • Publication Date: 30 Nov 2021
  • Publisher: Springer Publishing Co Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780826147486

About

Francis P. Worden MD is a Professor of Medicine and Director of the Hematology/Oncology Fellowship Program at the University of Michigan Medical School in Ann Arbor Michigan. Rami N. Khoriaty MD is an Associate Professor in the Department of Internal Medicine Division of Hematology/Oncology at the University of Michigan Medical School in Ann Arbor Michigan. Erin Cobain MD Chief Fellow Division of Hematology/Oncology University of Michigan Medical School Ann Arbor Michigan

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept